These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24072178)

  • 1. Discharge use of carvedilol is associated with higher survival in Japanese elderly patients with heart failure regardless of left ventricular ejection fraction.
    Yanagihara K; Kinugasa Y; Sugihara S; Hirai M; Yamada K; Ishida K; Kato M; Yamamoto K
    J Cardiovasc Pharmacol; 2013 Nov; 62(5):485-90. PubMed ID: 24072178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
    Massie BM; Nelson JJ; Lukas MA; Greenberg B; Fowler MB; Gilbert EM; Abraham WT; Lottes SR; Franciosa JA;
    Am J Cardiol; 2007 May; 99(9):1263-8. PubMed ID: 17478155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
    Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K; Park TH
    Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
    Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
    Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol produces sustained long-term benefits: follow-up at 12 years.
    MacGregor JF; Wachter SB; Munger M; Stoddard G; Bristow MR; Gilbert EM
    Congest Heart Fail; 2009; 15(1):5-8. PubMed ID: 19187400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
    Shore S; Aggarwal V; Zolty R
    J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
    Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
    Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.